What is Aurora Innovation's (Aur) stock price forecast?
Their AUR stock forecasts range from $4.00 to $14.25. On average, they anticipate Aurora Innovation's share price to reach $9.13 in the next twelve months.
What's happening with Aur stock?
Aurora Innovation's stock was trading at $11.26 at the beginning of the year. Since then, AUR stock has decreased by 77.9% and is now trading at $2.49.
Where can I buy Aur shares?
Shares of AUR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Is Aurora Innovation (Auro) a good buy on Wall Street?
Aurora Innovation has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings. According to analysts' consensus price target of $9.13, Aurora Innovation has a forecasted upside of 278.6% from its current price of $2.41.
What was Aurora highest stock price?
The all-time high Aurora Cannabis stock closing price was 119.57 on March 19, 2019.
What is the target price for Aurora?
Stock Price Target ACBHigh$4.00Median$2.34Low$1.55Average$2.48Current Price$1.43
What does Aurora sell?
Aurora Cannabis Inc. is a Canadian licensed cannabis producer, headquartered in Edmonton. It trades on the Toronto Stock Exchange and Nasdaq as ACB. As of late September 2018, Aurora Cannabis had eight licensed production facilities, five sales licences, and operations in 25 countries.
What brands are under Aurora?
The Company's portfolio of brands includes Aurora, Aurora Drift, San Rafael '71, Daily Special, MedReleaf, CanniMed, Whistler, Reliva and KG7 CBD.
Is ACB a buy or sell?
Today ACB ranks #12768 as sell candidate.
What is the outlook for canopy growth?
The 16 analysts offering 12-month price forecasts for Canopy Growth Corp have a median target of 3.32, with a high estimate of 10.09 and a low estimate of 1.99. The median estimate represents a +31.12% increase from the last price of 2.53.
Is Aurora a good buy?
The technical analysis of the Aurora Cannabis share price shows short-term buy signals but longer term sell signals with the following chart indicators: The RSI is currently at 33.431, which sends a strong buy signal on this stock.
Should I sell my ACB stock now?
The consensus among Wall Street equities research analysts is that investors should "hold" Aurora Cannabis stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ACB, but not buy additional shares or sell existing shares.
Will ACB ever recover?
Is Aurora Cannabis Expected To Recover? ACB management has guided for positive adjusted EBITDA by the first half of fiscal 2023. For reference, the most recent quarter was the third quarter of fiscal 2022, so positive adjusted EBITDA is expected within 3 quarters.
Will Aurora stock go up?
Aurora Cannabis Inc (NASDAQ:ACB) The 10 analysts offering 12-month price forecasts for Aurora Cannabis Inc have a median target of 2.34, with a high estimate of 4.00 and a low estimate of 1.44. The median estimate represents a +85.34% increase from the last price of 1.26.
Who bought Aurora?
Under the terms of the deal, a group of underwriters led Canaccord Genuity and BMO Capital Markets agreed to buy on bought-deal basis 51.1 million units of the company for $2.45 per unit.
Why has ACB stock dropped?
ACB, +2.27% ACB, -3.41% shares dropped 28% Friday after the cannabis company said it would increase the size of its bought deal financing to $150 million from $125 million.
Should I buy or sell Aurora Innovation stock right now?
2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aurora Innovation in the last twelve months. There are currently...
What is Aurora Innovation's stock price forecast for 2022?
2 Wall Street analysts have issued 1 year price objectives for Aurora Innovation's stock. Their forecasts range from $4.00 to $14.25. On average, t...
How has Aurora Innovation's stock price performed in 2022?
Aurora Innovation's stock was trading at $11.26 at the beginning of 2022. Since then, AUR stock has decreased by 78.3% and is now trading at $2.44....
When is Aurora Innovation's next earnings date?
Aurora Innovation is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022. View our earnings forecast for A...
How were Aurora Innovation's earnings last quarter?
Aurora Innovation, Inc. (NASDAQ:AUR) issued its quarterly earnings results on Wednesday, May, 4th. The company reported ($0.07) earnings per share...
Who are Aurora Innovation's key executives?
Aurora Innovation's management team includes the following people: Mr. Christopher Urmson Ph.D. , Co-Founder, Pres, CEO & Exec. Director (Age 45...
Who are some of Aurora Innovation's key competitors?
Some companies that are related to Aurora Innovation include Open Text (OTEX) , CACI International (CACI) , Samsara (IOT) , Science Application...
What is Aurora Innovation's stock symbol?
Aurora Innovation trades on the NASDAQ under the ticker symbol "AUR."
Who are Aurora Innovation's major shareholders?
Aurora Innovation's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (0.89...
What is Aurora Cannabis?
Where is Aurora Cannabis located?
(NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced a renewed sponsorship of Cannabis Amnesty in support of their advocacy work, calling for blanket pardons to all individuals for the offence of simple possession of cannabis. The sponsorship will support Cannabis Amnesty's campaign to right these historical wrongs – especially the impact on racialized communities.
Is Aurora Cannabis a rival to Canopy Growth?
Analyst Report: Aurora Cannabis Inc. Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that include Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.
Is Aurora Cannabis a SNDL?
Canadian pot producers Aurora Cannabis (NASDAQ: ACB) and Canopy Growth (NASDAQ: CGC) have been rivals for years. For the period ending Sept. 30, Canopy Growth reported revenue of 131.4 million Canadian dollars ($104 million). The company noted "continued price compression" in the Canadian market and more competition in international markets as some of the reasons its revenue hasn't been particularly strong of late.
Where is Aurora Innovation located?
Aurora Cannabis Inc (NASDAQ: ACB) is trading higher Friday in sympathy with Sundial Growers Inc (NASDAQ: SNDL), which reported its third-quarter financial results and announced a share repurchase program. Sundial reported quarterly net earnings of $11.3 million Canadian dollars ($8.99 million), which is up from a loss of CAD$71.4 million year-over-year. The company reported quarterly adjusted EBITDA of CAD$10.5 million, which is up from an adjusted EBITDA loss of CAD$4.4 million year-over-year.
Is there enough data for Aurora Innovation?
Aurora Innovation's mailing address is 215 PARK AVENUE FLOOR 11, NEW YORK NY, 10003. The company can be reached via phone at 212-457-1272 or via email at ir@aurora.tech.
Does Aurora Innovation pay dividends?
There is not enough analysis data for Aurora Innovation.
